Cooper Companies | COO - Le Bénéfice D'Exploitation

Prix De L'Action
64.42
Variation Quotidienne
-0.53 -0.82%
Mensuellement
-9.84%
Annuel
-20.36%
Q2 Prévisions
63.04




Le Bénéfice D'Exploitation Changement Date
Abbott USD 1.85B 399M 2026-03
Align Technology USD 224.71M 40.06M 2025-12
AtriCure USD 2.49M 2.28M 2025-12
Avanos Medical USD 24.77M 5.8M 2025-12
Bausch Health Companies USD 719M 2M 2025-12
Baxter International USD -214.2M 415.4M 2025-12
Bayer EUR 1.11B 1.65B 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Boston Scientific USD 1.24B 203M 2025-12
Cooper Companies USD 212.8M 72.4M 2025-12
Dentsply International USD 538M 26M 2025-12
Dexcom USD 323M 80.5M 2025-12
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Globus Medical USD 181.31M 298.83M 2025-12
Haemonetics USD 67.4M 8.9M 2025-12
Inogen USD -7.79M 728K 2024-09
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 859.7M 5.6M 2026-03
J&J USD 6.62B 1.03B 2026-03
Medtronic USD 1.74B 40M 2025-12
Merit Medical Systems USD 54.2M 11.58M 2025-12
Novartis USD 4.06B 521M 2025-12
ResMed USD 497.6M 35.25M 2025-12
STAAR Surgical USD -10.93M 29.42M 2025-12
Steris USD 278M 7.1M 2025-12
Stryker USD 1.97B 609M 2025-12
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 445.24M 2025-12
Utah Medical Products USD 2.44M 1.32M 2025-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12